Lonza ups stake in Octane, furthering cell therapy bet

Lonza ups stake in Octane, furthering cell therapy bet

Source: 
Biopharma Dive
snippet: 

Swiss contracting giant Lonza has increased its equity stake in Octane Biotech, acquiring a controlling stake along with an option to take full ownership for an undisclosed sum.